Cargando…

Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach

Astacin metalloproteinases, in particular meprins α and β, as well as ovastacin, are emerging drug targets. Drug‐discovery efforts have led to the development of the first potent and selective inhibitors in the last few years. However, the most recent compounds are based on a highly flexible tertiar...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Kathrin, Jäger, Christian, Körschgen, Hagen, Geissler, Stefanie, Schlenzig, Dagmar, Buchholz, Mirko, Stöcker, Walter, Ramsbeck, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048867/
https://www.ncbi.nlm.nih.gov/pubmed/33369214
http://dx.doi.org/10.1002/cmdc.202000822
_version_ 1783679313518788608
author Tan, Kathrin
Jäger, Christian
Körschgen, Hagen
Geissler, Stefanie
Schlenzig, Dagmar
Buchholz, Mirko
Stöcker, Walter
Ramsbeck, Daniel
author_facet Tan, Kathrin
Jäger, Christian
Körschgen, Hagen
Geissler, Stefanie
Schlenzig, Dagmar
Buchholz, Mirko
Stöcker, Walter
Ramsbeck, Daniel
author_sort Tan, Kathrin
collection PubMed
description Astacin metalloproteinases, in particular meprins α and β, as well as ovastacin, are emerging drug targets. Drug‐discovery efforts have led to the development of the first potent and selective inhibitors in the last few years. However, the most recent compounds are based on a highly flexible tertiary amine scaffold that could cause metabolic liabilities or decreased potency due to the entropic penalty upon binding to the target. Thus, the aim of this study was to discover novel conformationally constrained scaffolds as starting points for further inhibitor optimization. Shifting from flexible tertiary amines to rigid heteroaromatic cores resulted in a boost in inhibitory activity. Moreover, some compounds already exhibited higher activity against individual astacin proteinases compared to recently reported inhibitors and also a favorable off‐target selectivity profile, thus qualifying them as very suitable chemical probes for target validation.
format Online
Article
Text
id pubmed-8048867
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80488672021-04-20 Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach Tan, Kathrin Jäger, Christian Körschgen, Hagen Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Stöcker, Walter Ramsbeck, Daniel ChemMedChem Full Papers Astacin metalloproteinases, in particular meprins α and β, as well as ovastacin, are emerging drug targets. Drug‐discovery efforts have led to the development of the first potent and selective inhibitors in the last few years. However, the most recent compounds are based on a highly flexible tertiary amine scaffold that could cause metabolic liabilities or decreased potency due to the entropic penalty upon binding to the target. Thus, the aim of this study was to discover novel conformationally constrained scaffolds as starting points for further inhibitor optimization. Shifting from flexible tertiary amines to rigid heteroaromatic cores resulted in a boost in inhibitory activity. Moreover, some compounds already exhibited higher activity against individual astacin proteinases compared to recently reported inhibitors and also a favorable off‐target selectivity profile, thus qualifying them as very suitable chemical probes for target validation. John Wiley and Sons Inc. 2020-12-23 2021-03-18 /pmc/articles/PMC8048867/ /pubmed/33369214 http://dx.doi.org/10.1002/cmdc.202000822 Text en © 2020 The Authors. ChemMedChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Full Papers
Tan, Kathrin
Jäger, Christian
Körschgen, Hagen
Geissler, Stefanie
Schlenzig, Dagmar
Buchholz, Mirko
Stöcker, Walter
Ramsbeck, Daniel
Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach
title Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach
title_full Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach
title_fullStr Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach
title_full_unstemmed Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach
title_short Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold‐Hopping Approach
title_sort heteroaromatic inhibitors of the astacin proteinases meprin α, meprin β and ovastacin discovered by a scaffold‐hopping approach
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048867/
https://www.ncbi.nlm.nih.gov/pubmed/33369214
http://dx.doi.org/10.1002/cmdc.202000822
work_keys_str_mv AT tankathrin heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach
AT jagerchristian heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach
AT korschgenhagen heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach
AT geisslerstefanie heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach
AT schlenzigdagmar heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach
AT buchholzmirko heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach
AT stockerwalter heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach
AT ramsbeckdaniel heteroaromaticinhibitorsoftheastacinproteinasesmeprinameprinbandovastacindiscoveredbyascaffoldhoppingapproach